Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Study Suggests Blood Marker for Heart Disease

By HospiMedica staff writers
Posted on 28 Nov 2000
A study of more than 300 patients found that sphingolipid levels were highly correlated with the incidence and severity of coronary artery disease (CAD), suggesting that a simple, inexpensive blood test could predict the presence and extent of CAD. More...
The study, conducted by scientists from San Diego State University (CA, USA), was presented at the Scientific Sessions of the American Heart Association in New Orleans.

In the study, sphingolipid levels were correlated with CAD as measured by angiography. The results showed that these novel ischemia markers were better predictors of CAD than such conventional risk factors as age, gender, elevated cholesterol, and hypertension. Disease predictability was enhanced when the sphingolipid markers were combined with the strongest risk factors of age and gender to form a myocardial ischemia rating function (MIRF) test. The relative risk of CAD was found to be more than 10 times higher in patients with high MIRF scores. Moreover, the MIRF index was able to predict the number of coronary blood vessels obstructed by CAD.

"We conclude that the serum levels of sphingolipids are potentially strong and robust measures of CAD and may form the basis for a simple screening test to accurately determine the incidence and severity of cardiac ischemia,” said Roger A. Sabbadini, Ph.D., professor of biology at San Diego State University.



Related Links:
San Diego State Univ.

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.